A detailed history of Wells Fargo & Company transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 818,364 shares of VRTX stock, worth $411 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
818,364
Previous 900 90829.33%
Holding current value
$411 Million
Previous $376,000 101916.76%
% of portfolio
0.09%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $20 Million - $24.7 Million
50,797 Added 6.62%
818,364 $384 Million
Q1 2024

May 10, 2024

BUY
$407.69 - $446.08 $7.58 Million - $8.3 Million
18,601 Added 2.48%
767,567 $321 Million
Q4 2023

Feb 09, 2024

SELL
$343.0 - $410.68 $10.7 Million - $12.9 Million
-31,321 Reduced 4.01%
748,966 $305 Million
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $9.24 Million - $9.91 Million
-27,328 Reduced 3.38%
780,287 $271 Million
Q2 2023

Aug 15, 2023

BUY
$314.42 - $351.91 $8.02 Million - $8.98 Million
25,507 Added 3.26%
807,615 $284 Million
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $9.4 Million - $10.7 Million
33,181 Added 4.43%
782,108 $246 Million
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $8.39 Million - $9.43 Million
-29,344 Reduced 3.77%
748,927 $216 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $5.87 Million - $6.55 Million
-21,431 Reduced 2.68%
778,271 $225 Million
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $12.1 Million - $15 Million
-51,380 Reduced 6.04%
799,702 $225 Million
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $1.17 Million - $1.38 Million
5,278 Added 0.62%
851,082 $222 Million
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $50.6 Million - $63.9 Million
-285,787 Reduced 25.26%
845,804 $186 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $7.58 Million - $8.48 Million
-41,789 Reduced 3.56%
1,131,591 $205 Million
Q2 2021

Aug 16, 2021

SELL
$187.49 - $221.1 $10.6 Million - $12.5 Million
-56,679 Reduced 4.61%
1,173,380 $237 Million
Q1 2021

May 13, 2021

SELL
$207.02 - $241.31 $15.5 Million - $18.1 Million
-75,085 Reduced 5.75%
1,230,059 $264 Million
Q4 2020

Feb 09, 2021

SELL
$207.01 - $276.09 $35.2 Million - $47 Million
-170,206 Reduced 11.54%
1,305,144 $308 Million
Q3 2020

Nov 05, 2020

SELL
$255.65 - $303.1 $13.2 Million - $15.7 Million
-51,698 Reduced 3.39%
1,475,350 $401 Million
Q2 2020

Aug 13, 2020

BUY
$225.48 - $295.8 $42.2 Million - $55.4 Million
187,264 Added 13.98%
1,527,048 $443 Million
Q1 2020

May 14, 2020

BUY
$199.77 - $247.81 $268 Million - $332 Million
1,339,784 New
1,339,784 $319 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.